DAUNORUBICIN ACCUMULATION BY HUMAN MYELOBLASTS VARYING IN ANTHRACYCLINE RESISTANCE

被引：18

作者：

KESSEL, D

WILBERDING, C

KARANES, C

RATANATHARATHORN, V

机构：

[1] WAYNE STATE UNIV,SCH MED,DEPT PHARMACOL,DETROIT,MI 48201

[2] HARPER GRACE HOSP,DETROIT,MI 48201

来源：

CANCER LETTERS | 1984年 / 24卷 / 03期

关键词：

D O I：

10.1016/0304-3835(84)90027-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：305 / 309

页数：5

共 19 条

[11]

KESSEL D, 1969, CANCER RES, V29, P459

[12] MODE OF ACTION OF CALCIUM-ANTAGONISTS WHICH ALTER ANTHRACYCLINE RESISTANCE [J].

KESSEL, D ;

WILBERDING, C .

BIOCHEMICAL PHARMACOLOGY, 1984, 33 (07) :1157-1160

[13] TRANSPORT AND BINDING OF DAUNORUBICIN, ADRIAMYCIN, AND RUBIDAZONE IN EHRLICH ASCITES TUMOR-CELLS [J].

SKOVSGAARD, T .

BIOCHEMICAL PHARMACOLOGY, 1977, 26 (03) :215-222

[14]

SKOVSGAARD T, 1978, CANCER RES, V38, P1785

[15]

SKOVSGAARD T, 1984, CANCER TREAT REV

[16] VERAPAMIL RESTORATION OF DAUNORUBICIN RESPONSIVENESS IN DAUNORUBICIN-RESISTANT EHRLICH ASCITES-CARCINOMA [J].

SLATER, LM ;

MURRAY, SL ;

WETZEL, MW ;

WISDOM, RM ;

DUVALL, EM .

JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (05) :1131-1134

[17] ENHANCEMENT OF VINCRISTINE-INDUCED AND ADRIAMYCIN-INDUCED CYTO-TOXICITY BY VERAPAMIL IN P388 LEUKEMIA AND ITS SUBLINES RESISTANT TO VINCRISTINE AND ADRIAMYCIN [J].

TSURUO, T ;

IIDA, H ;

YAMASHIRO, M ;

TSUKAGOSHI, S ;

SAKURAI, Y .

BIOCHEMICAL PHARMACOLOGY, 1982, 31 (19) :3138-3140

[18]

TSURUO T, 1982, CANCER RES, V42, P4730

[19]

TSURUO T, 1981, CANCER RES, V41, P1967

← 1 2 →